Virax Biolabs Collaborates with Emory University to Advance Long COVID Diagnostic Studies

Virax Biolabs has signed a research pact with Emory University's ADJUST Center to advance clinical studies of its proprietary T cell testing technology, ViraxImmune, for diagnosing long COVID. The studies will focus on immune profiling in individuals with post-viral syndromes, and the collaboration aligns with Virax's preparations for a pre-submission meeting with the FDA. The partnership aims to validate ViraxImmune in real-world patient populations and create long-term value for shareholders.